NASDAQ:VNDA
Vanda Pharmaceuticals Inc.
- Stock
Last Close
4.41
06/11 21:01
Market Cap
303.21M
Beta: 0.70
Volume Today
346.29K
Avg: 585.01K
PE Ratio
17.10
PFCF: 7.88
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.85M - | 3.23M 13.40% | 1.04M 67.93% | 809.50K 21.90% | 917K 13.28% | 1.07M 16.36% | 1.21M 13.40% | 1.15M 4.75% | 1.11M 3.73% | 1.28M 14.96% | |
average payables | 748K - | 8.30M 1,009.76% | 15.98M 92.52% | 18.27M 14.29% | 10.17M 44.33% | 462.50K - | 6.81M 1,371.89% | 6.34M 6.79% | |||
average receivables | 2.84M - | 9.99M 251.54% | 18.30M 83.13% | 18.93M 3.47% | 23.19M 22.48% | 27.57M 18.90% | 28.20M 2.28% | 31.25M 10.82% | 32.99M 5.56% | 33.83M 2.56% | |
book value per share | 4.62 - | 3.15 31.92% | 3.02 4.00% | 2.94 2.83% | 5.42 84.38% | 7.73 42.81% | 8.33 7.68% | 9.09 9.15% | 9.34 2.72% | 0.01 99.90% | |
capex per share | -0.25 - | -0.06 76.28% | -0.03 45.86% | -0.04 14.87% | -0.50 1,240.93% | -0.02 96.16% | -0.03 71.98% | -0.01 69.87% | -0.01 21.02% | -0.00 99.94% | |
capex to depreciation | -3.15 - | -0.19 94.08% | -0.12 36.41% | -0.56 370.37% | -8.58 1,438.96% | -0.35 95.89% | -0.63 77.88% | -0.19 69.00% | -0.25 27.87% | 0.05 119.57% | |
capex to operating cash flow | 0.11 - | -0.20 288.78% | 0.17 185.54% | 0.84 383.26% | -0.85 200.82% | -0.02 97.38% | -0.03 56.32% | -0.01 75.20% | -0.02 146.96% | -0.03 40.93% | |
capex to revenue | -0.17 - | -0.02 86.85% | -0.01 58.08% | -0.01 4.61% | -0.13 1,203.20% | -0.00 96.59% | -0.01 61.26% | -0.00 71.60% | -0.00 29.92% | -0.00 25.51% | |
cash per share | 3.73 - | 3.39 9.23% | 3.25 4.01% | 3.21 1.45% | 5.06 57.84% | 5.87 16.08% | 6.76 15.02% | 7.79 15.32% | 8.27 6.12% | 0.01 99.92% | |
days of inventory on hand | 1.19K - | 20.13 98.31% | 11.51 42.84% | 17.18 49.30% | 17.69 2.98% | 16.99 3.95% | 20.00 17.68% | 14.60 27.00% | 17.95 22.95% | ||
days payables outstanding | 192.53 - | 245.29 27.40% | 239.22 2.48% | 415.86 73.84% | 13.17 - | 190.75 1,348.00% | |||||
days sales outstanding | 26.59 - | 54.23 103.93% | 50.66 6.57% | 38.92 23.19% | 54.40 39.78% | 42.36 22.12% | 44.18 4.28% | 44.11 0.16% | 48.08 9.02% | 64.71 34.58% | |
debt to assets | 0.04 - | 0.03 - | 0.03 15.45% | 0.02 18.40% | 0.02 15.65% | 0.01 38.49% | |||||
debt to equity | 0.04 - | 0.04 - | 0.03 15.47% | 0.02 18.46% | 0.02 13.71% | 0.01 39.16% | |||||
dividend yield | |||||||||||
earnings yield | 0.04 - | -0.10 350.01% | -0.03 74.36% | -0.02 11.91% | 0.02 182.85% | 0.13 598.63% | 0.03 75.38% | 0.04 16.57% | 0.02 60.46% | 0.00 99.93% | |
enterprise value | 437.07M - | 342.51M 21.63% | 652.59M 90.53% | 646.35M 0.96% | 1.27B 96.17% | 839.37M 33.80% | 667.76M 20.44% | 829.53M 24.23% | 293.37M 64.63% | 242.02B 82,397.46% | |
enterprise value over ebitda | -3.29 - | -12.59 282.76% | -85.44 578.84% | -42.65 50.08% | 54.50 227.77% | 34.52 36.66% | 22.18 35.74% | 19.01 14.31% | 37.40 96.74% | -17.35K 46,487.08% | |
ev to operating cash flow | -5.36 - | 27.51 613.37% | -80.54 392.73% | -325.94 304.71% | 42.29 112.97% | 18.27 56.80% | 12.90 29.40% | 12.92 0.16% | 9.17 29.00% | 18.91K 206,024.43% | |
ev to sales | 8.71 - | 3.12 64.24% | 4.47 43.44% | 3.92 12.40% | 6.57 67.70% | 3.69 43.73% | 2.69 27.17% | 3.09 14.74% | 1.15 62.65% | 1.26K 108,838.27% | |
free cash flow per share | -2.60 - | 0.23 109.04% | -0.22 193.20% | -0.08 62.75% | 0.09 211.38% | 0.85 831.19% | 0.92 8.61% | 1.15 24.81% | 0.55 51.62% | 0.00 99.96% | |
free cash flow yield | -0.18 - | 0.03 113.91% | -0.01 154.40% | -0.01 60.92% | 0.00 164.79% | 0.05 1,382.75% | 0.07 35.64% | 0.07 4.52% | 0.08 2.71% | 0.00 99.93% | |
graham net net | 3.57 - | 1.80 49.63% | 1.79 0.41% | 1.86 3.50% | 4.38 136.05% | 4.89 11.59% | 5.71 16.82% | 6.64 16.30% | 6.83 2.84% | 0.01 99.92% | |
graham number | 7.77 - | 8.18 5.20% | 5.31 35.06% | 4.80 9.68% | 7.77 62.06% | 19.45 150.32% | 8.96 53.92% | 11.05 23.26% | 4.83 56.26% | 0.00 99.94% | |
income quality | -4.04 - | -0.31 92.27% | 0.45 244.08% | 0.13 71.69% | 1.19 833.82% | 0.40 66.57% | 2.22 457.95% | 1.94 12.69% | 5.10 163.15% | 5.10 0.10% | |
intangibles to total assets | 0.16 - | 0.18 16.87% | 0.13 27.30% | 0.13 4.03% | 0.07 41.77% | 0.05 35.55% | 0.04 15.14% | 0.03 16.32% | 0.03 13.45% | 0.19 539.44% | |
interest coverage | -1.27 - | ||||||||||
interest debt per share | 0.19 - | 0.27 - | 0.25 8.98% | 0.22 11.00% | 0.11 50.91% | 0.00 99.89% | |||||
inventory turnover | 0.31 - | 18.13 5,821.62% | 31.72 74.96% | 21.25 33.02% | 20.63 2.90% | 21.48 4.11% | 18.25 15.03% | 25.00 36.98% | 20.34 18.67% | ||
invested capital | 0.04 - | 0.04 - | 0.03 15.47% | 0.02 18.46% | 0.02 13.71% | 0.01 39.16% | |||||
market cap | 497.97M - | 393.35M 21.01% | 693.02M 76.18% | 679.97M 1.88% | 1.33B 95.44% | 871.99M 34.39% | 715.18M 17.98% | 871.55M 21.86% | 417.25M 52.13% | 242.15B 57,933.75% | |
net current asset value | 130.84M - | 86.52M 33.87% | 95.13M 9.95% | 95.82M 0.72% | 242.42M 153.00% | 281.33M 16.05% | 328.95M 16.93% | 389.44M 18.39% | 412.24M 5.86% | 329.42M 20.09% | |
net debt to ebitda | 0.46 - | 1.87 307.76% | 5.29 183.29% | 2.22 58.07% | -2.62 218.16% | -1.34 48.84% | -1.58 17.42% | -0.96 38.88% | -15.79 1,540.35% | 9.23 158.46% | |
net income per share | 0.58 - | -0.94 262.54% | -0.41 56.07% | -0.35 16.05% | 0.50 242.43% | 2.17 338.75% | 0.43 80.28% | 0.60 39.19% | 0.11 81.38% | 0.00 99.96% | |
operating cash flow per share | -2.35 - | 0.29 112.56% | -0.19 163.29% | -0.04 76.23% | 0.59 1,430.05% | 0.86 46.66% | 0.95 10.01% | 1.16 21.52% | 0.57 51.00% | 0.00 99.96% | |
payables turnover | 1.90 - | 1.49 21.51% | 1.53 2.54% | 0.88 42.48% | 27.71 - | 1.91 93.09% | |||||
receivables turnover | 13.73 - | 6.73 50.96% | 7.20 7.03% | 9.38 30.19% | 6.71 28.46% | 8.62 28.41% | 8.26 4.11% | 8.28 0.16% | 7.59 8.27% | 5.64 25.70% | |
research and ddevelopement to revenue | 0.38 - | 0.27 30.85% | 0.20 24.69% | 0.23 16.94% | 0.23 3.32% | 0.21 5.14% | 0.22 4.58% | 0.28 25.25% | 0.34 20.21% | 0.40 18.28% | |
return on tangible assets | 0.14 - | -0.23 264.27% | -0.10 56.87% | -0.09 12.02% | 0.08 194.42% | 0.25 206.04% | 0.05 81.82% | 0.06 26.75% | 0.01 82.36% | 0.00 53.29% | |
revenue per share | 1.44 - | 2.60 80.38% | 3.36 29.17% | 3.69 9.81% | 3.80 2.89% | 4.28 12.60% | 4.56 6.65% | 4.84 6.08% | 4.51 6.85% | 0.00 99.93% | |
roe | 0.13 - | -0.30 338.74% | -0.14 54.24% | -0.12 13.60% | 0.09 177.25% | 0.28 207.23% | 0.05 81.69% | 0.07 27.52% | 0.01 81.87% | 0.00 61.32% | |
roic | 0.58 - | -0.30 152.08% | -0.14 52.92% | -0.13 8.75% | 0.08 160.48% | 0.21 164.10% | 0.04 79.84% | 0.06 49.71% | 0.01 89.73% | -0.01 253.82% | |
sales general and administrative to revenue | 1.69 - | 0.77 54.43% | 0.68 11.13% | 0.75 9.77% | 0.55 27.00% | ||||||
shareholders equity per share | 4.62 - | 3.15 31.92% | 3.02 4.00% | 2.94 2.83% | 5.42 84.38% | 7.73 42.81% | 8.33 7.68% | 9.09 9.15% | 9.34 2.72% | 0.01 99.90% | |
stock based compensation to revenue | 0.12 - | 0.07 38.20% | 0.06 19.21% | 0.06 8.35% | 0.06 4.71% | 0.06 1.94% | 0.05 9.12% | 0.06 6.29% | 0.06 11.84% | 0.07 13.89% | |
tangible asset value | 134.09M - | 94.28M 29.69% | 103.51M 9.80% | 105.32M 1.75% | 250.88M 138.21% | 387.91M 54.62% | 431.71M 11.29% | 484.85M 12.31% | 508.63M 4.91% | 423.54M 16.73% | |
tangible book value per share | 3.86 - | 2.23 42.13% | 2.38 6.77% | 2.35 1.18% | 4.93 109.53% | 7.30 47.99% | 7.93 8.65% | 8.73 10.04% | 9.01 3.21% | 0.01 99.92% | |
working capital | 133.94M - | 115.23M 13.97% | 123.86M 7.49% | 99.49M 19.67% | 246.12M 147.37% | 294.63M 19.71% | 343.21M 16.49% | 403.88M 17.68% | 427.86M 5.94% | 345.25M 19.31% |
All numbers in USD (except ratios and percentages)